ESMO Poster Presentation Highlights ... Inc., is a clinical-stage company relentlessly focused on the discovery and development of precisely designed cancer therapeutics, to transform what science can ...

The following posters will be presented ... Idorsia is specialized in the discovery, development and commercialization of ...

GlyTherix Ltd (GlyTherix) an Australian targeted radiotherapy company specializing in developing antibody ...

Celonis, the global leader in Process Mining and Process Intelligence, today announced an enterprise expansion agreement with Samsung Fire & Marine Insurance (SFMI), the largest property and casualty ...

A new therapeutic agent discovered and developed at The Ohio State University will soon be used for cancer treatment at the ...

Focus will be given to the latest advances in small molecule drug discovery and development, biopharma and biotechnology. This online symposium will explore: Leveraging AI for transformative drug ...

(luvelta) in combination with standard dose of bevacizumab (15 mg/kg) every 3 weeks resulted in a 56% objective response rate in patients with late-stage ovarian cancer and was selected to be the ...

We considered it worthwhile to compare the common genetic lesions that have been found in various cancers (by both DNA sequencing and other discovery ... for patients with drug-resistant tumours ...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger ...

The term "digital twins" has its origins in engineering and computer science ... or a drug manufacturing process. Digital twins have tremendous potential to revolutionise drug discovery and ...

The National Academies of Sciences, Engineering, and Medicine are the nation's pre-eminent source of high-quality, objective advice on science, engineering, and health matters. Top experts participate ...

Three scientists are honored for developing a class of blockbuster weight-loss drugs. Is a Nobel prize on the way?